Alnylam Pharma (ALNY) Tops Q1 EPS by 37c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $251.65 --0%
Revenue Growth %: +15.3%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +15.3%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.52), $0.37 better than the analyst estimate of ($1.89). Revenue for the quarter came in at $99.5 million versus the consensus estimate of $91.56 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- B. Riley previews Semi Cap Equipment sector ahead of Semicon West
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
